EW vs IQST · P/E 47, rev $3.39B vs rev $207.0M
Edwards Lifesciences Corp (EW) versus Iqstel Inc (IQST) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Iqstel Inc (IQST) is a telecom services company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported IQST revenue for 2026-06-30 was $207.0M. Net income was -$3.8M. IQST currently screens at market cap $6.5M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. IQST currently screens at market cap $6.5M.
Not investment advice. Open the EW and IQST stock pages for the full models.
Not investment advice.